News
Identifying Drug-Induced Rashes in Skin of Color: Heightened Awareness Can Accelerate Diagnosis
In patients with DIHS and many of the even more serious types of rashes traced to drug exposures, the delay to appearance of the rash from the...
News
FDA Initiative Aims to Improve Diversity in Clinical Trials
This initiative could be a critical step toward ensuring diversity in major clinical trials after years of stagnation, Dr. Valerie Harvey said.
News
Positive Stem Cell Transplant Data Is Increasing Its Use
The growing quantity of real-world data supporting hematopoietic stem cell transplant for MS is driving its growing routine application at centers...
News
Skip Potassium After Cardiac Surgery
Postoperative atrial fibrillation risks is not altered with potassium supplementation for patients who recently had CV surgery, says study.
News
New AFib Guidelines Address Underlying Illness, Comorbidities
Class I recommendations have been issued for comorbidity, risk factor management goals, including those BP, HF, diabetes, etc.
News
Less Invasive, Overlooked Option in Cardiac Surgery May Offer Benefit
Sutureless valves are an alternative to SAVR and TAVR, but are used less often and have less data.
News
Gout Drugs in Late-Phase Trials Might Increase Patients at Target Urate Level
New options in late stages of clinical testing for refractory gout promise to increase the chances of reaching the guideline uric acid target with...
News
CAR T-Cell Treatment Data Expands in Refractory Rheumatic Diseases, Demonstrating Consistent Efficacy
Numerous cases and case series presented at EULAR 2024 add to a rapidly growing collection of evidence that CAR T-cell therapy will be a...
News
Pediatric Studies Produce Mixed Messages on Relationship Between COVID and Asthma
The most recent of several studies exploring the impact of COVID-19 infection on children with asthma suggests vaccination reduces asthma symptoms...
News
First-line Canakinumab Without Steroids Shows Effectiveness for Systemic Juvenile Idiopathic Arthritis
For JIA, a disease with limited options, a three-injection course of canakinumab was associated with durable control of disease in the absence of...
News
Nurse-Led Care for Gout Generates Best Uric Acid Control
In gout management the treatment target is clear and nurses are often able to devote more time to a specific goal.
News
Why Do Investigational OA Drugs Need Better Trial Endpoints? Lorecivivint Serves as an Example
The reason that disease-modifying osteoarthritis drugs remain elusive might be due to trial designs and targets not optimized for showing disease-...
News
Ixekizumab Met Phase 3 Trial Endpoint in Juvenile PsA, Enthesitis-Related Arthritis
Ixekizumab has taken a major step toward its approval for the treatment of psoriatic arthritis and enthesitis-related arthritis in children, based...
News
Shift Needed in Research, Treatment, Care for Aging MS Population
Independent of disease progression, the impact of aging on MS has been underappreciated in research and in clinical practice.